• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[糖尿病晚期并发症的可能遗传原因]

[Possible genetic causes for late complications of diabetes mellitus].

作者信息

Klemm T, Paschke R

机构信息

Medizinische Klinik und Poliklinik III, Universität Leipzig.

出版信息

Med Klin (Munich). 2000 Jan 15;95(1):31-9. doi: 10.1007/BF03044978.

DOI:10.1007/BF03044978
PMID:10668342
Abstract

BACKGROUND

Hyperglycemia occurs in every patient with diabetes mellitus. It is the most important factor in the development of diabetic complications. However, the onset, intensity and the progression of complications show large interindividual variations. Manifestation in families and the lack of complications in some diabetics with poor metabolic control indicate a genetic predisposition to develop diabetic complications like nephropathy, neuropathy and angiopathy.

NEPHROPATHY

Diabetic nephropathy occurs only in 25 to 40% of the diabetic patients. Therefore a genetic risk factor for this complication is very likely. Various variations in genes like ACE-gene and angiotensinogen-gene have been described, which could be associated with the development of diabetic nephropathy.

NEUROPATHY

Peripheral diabetic neuropathy occurs in up to 66% of all diabetics. Therefore and because of the possible pathological mechanisms genetic risk factors like variations in the Na/K-ATPase-gene and in the aldose reductase-gene are discussed.

RETINOPATHY

An association between diabetic retinopathy and polymorphisms in the ACE-gene and the aldose reductase-gene seems very unlikely, because up to 75% of the diabetic patients suffer from retinopathy after 15 years of diabetes.

MACROANGIOPATHY

A large number of studies show an association between diabetic macroangiopathy and genetic variations in the ACE-gene (I/D-variant) and the paraoxonase-gene (2 isoforms).

CONCLUSION

Based on the current evidence for associations of genetic markers with diabetic complications, the generation of an individual risk profile based on genetic markers seems to be possible. In addition to near euglycemia genetic markers could direct therapeutic strategies and lead to new therapeutic approaches.

摘要

背景

每位糖尿病患者都会出现高血糖。它是糖尿病并发症发生发展的最重要因素。然而,并发症的发作、严重程度和进展存在很大的个体差异。家族中的表现以及一些代谢控制不佳的糖尿病患者未出现并发症,表明存在发生糖尿病肾病、神经病变和血管病变等糖尿病并发症的遗传易感性。

肾病

仅25%至40%的糖尿病患者会发生糖尿病肾病。因此,这种并发症很可能存在遗传风险因素。已描述了诸如ACE基因和血管紧张素原基因等基因的各种变异,它们可能与糖尿病肾病的发生有关。

神经病变

高达66%的糖尿病患者会发生周围性糖尿病神经病变。因此,鉴于可能的病理机制,人们讨论了诸如钠钾ATP酶基因和醛糖还原酶基因变异等遗传风险因素。

视网膜病变

糖尿病视网膜病变与ACE基因和醛糖还原酶基因多态性之间似乎不太可能存在关联,因为高达75%的糖尿病患者在患糖尿病15年后会出现视网膜病变。

大血管病变

大量研究表明糖尿病大血管病变与ACE基因(I/D变异)和对氧磷酶基因(2种同工型)的遗传变异有关。

结论

基于目前关于遗传标记与糖尿病并发症关联的证据,似乎有可能根据遗传标记生成个体风险概况。除了接近正常血糖水平外,遗传标记还可以指导治疗策略并带来新的治疗方法。

相似文献

1
[Possible genetic causes for late complications of diabetes mellitus].[糖尿病晚期并发症的可能遗传原因]
Med Klin (Munich). 2000 Jan 15;95(1):31-9. doi: 10.1007/BF03044978.
2
[The late diabetic syndrome and its correlations with hereditary factors].[晚期糖尿病综合征及其与遗传因素的相关性]
Folia Clin Int (Barc). 1968 Jan;18(1):20-33.
3
[Genetic susceptibility to microangiopathy development in Type 1 diabetes mellitus].1型糖尿病微血管病变发生的遗传易感性
Arq Bras Endocrinol Metabol. 2008 Mar;52(2):375-86. doi: 10.1590/s0004-27302008000200026.
4
[Genetic risk factors for diabetic complications].[糖尿病并发症的遗传风险因素]
Harefuah. 1997 Jun 15;132(12):862-6.
5
[Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].2型糖尿病患者血管紧张素I转换酶基因I/D多态性与微血管并发症的关系
Przegl Lek. 2007;64(3):134-9.
6
The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients.Toll样受体4基因多态性对2型糖尿病患者血管并发症的影响。
Diabetes Res Clin Pract. 2016 Jun;116:7-13. doi: 10.1016/j.diabres.2016.04.002. Epub 2016 Apr 26.
7
The genetics of diabetic complications.糖尿病并发症的遗传学。
Nat Rev Nephrol. 2015 May;11(5):277-87. doi: 10.1038/nrneph.2015.37. Epub 2015 Mar 31.
8
Genetic Variants and Their Associations to Type 2 Diabetes Mellitus Complications in the United Arab Emirates.阿联酋 2 型糖尿病并发症的遗传变异及其相关性。
Front Endocrinol (Lausanne). 2022 Jan 6;12:751885. doi: 10.3389/fendo.2021.751885. eCollection 2021.
9
TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy.TCF7L2 基因多态性与 2 型糖尿病:与糖尿病视网膜病变和心血管自主神经病变的关系。
Acta Diabetol. 2013 Oct;50(5):789-99. doi: 10.1007/s00592-012-0418-x. Epub 2012 Jul 28.
10
Genetic analysis of aldose reductase in diabetic complications.糖尿病并发症中醛糖还原酶的遗传分析。
Curr Med Chem. 2003 Aug;10(15):1375-87. doi: 10.2174/0929867033457322.

引用本文的文献

1
WenTong HuoXue Cream Can Inhibit the Reduction of the Pain-Related Molecule PLC-3 in the Dorsal Root Ganglion of a Rat Model of Diabetic Peripheral Neuropathy.万通活血膏可抑制糖尿病周围神经病变大鼠模型背根神经节中疼痛相关分子PLC-3的减少。
Evid Based Complement Alternat Med. 2018 Feb 11;2018:3416936. doi: 10.1155/2018/3416936. eCollection 2018.
2
Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project.祖尼印第安人中乙二醛酶I多态性的分布:祖尼肾脏项目
J Diabetes Complications. 2008 Jul-Aug;22(4):267-72. doi: 10.1016/j.jdiacomp.2007.06.010. Epub 2008 Apr 16.

本文引用的文献

1
Hyperglycemia and cardiovascular disease in type 2 diabetes.2型糖尿病中的高血糖与心血管疾病
Diabetes. 1999 May;48(5):937-42. doi: 10.2337/diabetes.48.5.937.
2
Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins.日本早发型非胰岛素依赖型糖尿病患者肝细胞核因子-1α基因突变的鉴定及突变蛋白的功能分析。
Diabetes. 1999 Mar;48(3):645-8. doi: 10.2337/diabetes.48.3.645.
3
The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus.
醛糖还原酶基因在II型(非胰岛素依赖型)糖尿病肾病易感性中的作用。
Diabetologia. 1999 Jan;42(1):94-7. doi: 10.1007/s001250051119.
4
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较(英国前瞻性糖尿病研究[UKPDS 33])。英国前瞻性糖尿病研究(UKPDS)小组
Lancet. 1998 Sep 12;352(9131):837-53.
5
Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.德国1型和2型糖尿病患者的载脂蛋白E多态性与肾功能
Diabetes Care. 1998 Jun;21(6):994-8. doi: 10.2337/diacare.21.6.994.
6
Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.皮马族2型糖尿病患者微血管并发症易感性基因的同胞对连锁分析。皮马糖尿病基因研究小组。
Diabetes. 1998 May;47(5):821-30. doi: 10.2337/diabetes.47.5.821.
7
The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population.1型糖尿病患者人群中2型糖尿病家族史与冠状动脉疾病之间的关联。
Diabetes Care. 1998 Apr;21(4):610-4. doi: 10.2337/diacare.21.4.610.
8
Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients.血管紧张素原T235和ACE插入/缺失多态性与中国2型糖尿病患者蛋白尿的相关性
Diabetes Care. 1998 Mar;21(3):431-7. doi: 10.2337/diacare.21.3.431.
9
Homocysteine and atherothrombosis.同型半胱氨酸与动脉粥样硬化血栓形成
N Engl J Med. 1998 Apr 9;338(15):1042-50. doi: 10.1056/NEJM199804093381507.
10
Enhanced G protein activation in IDDM patients with diabetic nephropathy.糖尿病肾病的IDDM患者中G蛋白激活增强。
Diabetologia. 1998 Jan;41(1):94-100. doi: 10.1007/s001250050872.